Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design.
Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord. 2010 Mar 15; 25(4):426-32.
View in:
PubMed
subject areas
Activities of Daily Living
Adult
Aged
Clinical Trials as Topic
Disease Progression
DNA, Mitochondrial
Double-Blind Method
Female
Friedreich Ataxia
Humans
Iron-Binding Proteins
Male
Middle Aged
Neurologic Examination
Point Mutation
Severity of Illness Index
Speech Disorders
Trinucleotide Repeats
Walking
Young Adult
authors with profiles
Christopher M. Gomez